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Abstract
Background  Obesity and aging are increasing globally and are known to be associated with adipose tissue and vascular stiff-
ness, which are emerging as risk factors for the development of cardiometabolic and neurodegenerative diseases such as 
atherosclerosis, hypertension, type 2 diabetes mellitus (T2DM), metabolic syndrome, and Alzheimer’s disease.  Therefore, we 
wished to test the hypothesis that the descending thoracic aorta may demonstrate aberrant ultrastructural remodeling that is 
ameliorated by empagliflozin, a sodium/glucose cotransporter 2 (SGLT2) inhibitor.  
Methods Ten-week-old female wild-type control (C57BLKS/J) and db/db (BKS.Cg-Dock7m+/+Leprdb/J) mice were divided into 
three groups: lean untreated controls (CKC, n = 6), untreated db/db controls (DBC, n = 6) and DBC treated with empagliflozin 
(EMPA treated with 10 mg/kg/day for 10 weeks) (DBE, n = 6). 
Results This study focuses on ultrastructural remodeling of tunica adventitia and tunica adiposa (periadventitial adipose tissue) 
of the descending aorta in both DBC and DBE mice.  In DBC mice (untreated db/db controls), major observational remodeling 
included  differentiation from thermogenic brown adipose tissue to white adipose tissue with hypertrophy of white adipocytes; 
ruptured plasma membranes and liberation of toxic lipids into the matrix, which incited inflammation with mast cells and mac-
rophages. These changes were ameliorated in DBE mice (DBC treated  with empagliflozin).
Conclusion  Aberrant ultrastructural findings in DBC versus CKC and the amelioration with EMPA may provide better under-
standing how obesity and T2DM promote increased risk of vascular stiffness; a milieu for developing cardiovascular disease and 
target end-organ damage including nerve, retina, kidney and brain.  Additionally, these findings may help us to better under-
stand why obesity and T2DM result in the loss of homeostatic anticontractile function of tunica adiposa. 
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Introduction
The cardiometabolic diseases (CMD) such as atherosclerosis, 
hypertension, obesity,  type 2 diabetes mellitus (T2DM) and 
metabolic syndrome (MetS) are increasing in prevalence glob-
ally and are expected to continue to increase during the com-
ing decades (1).  These conditions are associated with cardio-
metabolic disease and target end-organ diseases, which include 
diabetic neuropathy, retinopathy, cardiomyopathy, nephropathy, 
vasculopathy and diabetic cognopathy in addition to late onset 
Alzheimer’s disease (LOAD) (2-9).  The adventitia’s outermost 
adipose tissue layer appears as a distinct entity and is commonly 
referred to as the perivascular adipose tissue (PVAT) or vascular 
periadventitial adipose tissue (PAAT), which was recently des-
ignated tunica adiposa (hereafter termed adiposa)  comprised 
of adipocytes and stromal-vascular cells (10-12).  Upon closer 
examination one can further discern two subdivisions of the 
adventitia from luminal side to the most abluminal side of the 
descending aorta: (i) tunica compacta (primarily comprised of 
type 1 collagen, and (ii) tunica lucida (primarily type III loose 
areolar collagen).  Interestingly, the adiposa volume can exceed 
the volume of the entire descending aorta in the diabetic db/
db aorta that in controls is comprised by a much thinner and 
almost exclusive thermogenic brown adipose tissue (BAT) of 
multilocular adipocytes.
Because of the marked aberrant remodeling in the adiposa, the 
latter became the major focus due to the marked differentiation of 
the multilocular thermogenic non-inflammatory BAT in control 
female (CKC) models to the unilocular pro-inflammatory white 
adipose tissue (WAT) in the female db/db (DBC) adiposa.  In the 
normal lean non-diabetic CKC thoracic descending aorta, the ad-
iposa consists primarily of BAT; however, in the DBC the adiposa 
undergoes a near complete differentiation of BAT to WAT (Fig. 1).
Figure 1.  This illustration demonstrates the thermogenic multilocular brown adipose tissue (BAT) of the adiposa as in control 
CKC (panel A).  In contrast, the DBC adiposa demonstrates marked and almost exclusive differentiation to unilocular white adi-
pose tissue (WAT) (panel B). Notably, these two illustrations are not created to any scale.  Interestingly, when the DBC is treated 
for 10-weeks with empagliflozin the adiposa is protected from this differentiation to WAT(not illustrated).  Specimens for this ul-
trastructure study were obtained from the regions bounded by the two yellow bars labeled (Upper 1/3).  Scale bars in  transmis-
sion electron micrographs inserts = 2µm; magnification x800 in panels A and B.   AGE, advanced glycation end products; ALDO, 
aldosterone; BAT, brown adipose tissue; DESC, descending aorta;   EC DYS, endothelial dysfunction; FFA, free fatty acids; H2S, 
hydrogen sulfide; OS, oxidative stress; Ld,  lipid droplets; MR, mineralocorticoid receptor; Mt,  mitochondria; MΦ, macrophage; 
NO, nitric oxide;  RAGE, receptor for advanced glycation end products; RAAS,  renin angiotensin-aldosterone system; ROS, reac-
tive oxygen species; WAT, white adipose tissue. 
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Since the initial recognition that adipose tissue, including 
vascular adiposa, is a highly active endocrine, paracrine and 
autocrine organ, there has been a substantial body of research 
devoted to this topic (10-12).  In addition to the endocrine 
functions the adiposa structurally contains an stromal-vascular 
fraction, which is comprised of endothelial cells, pericytes and 
adipose precursor cells with resident mast cells as first respond-
ers to injury and the potential to assemble a large variety of  cir-
culatory inflammatory cells including mostly macrophages and 
fewer lymphocytes.    
Conduit and resistant arterial stiffness in obesity and T2DM 
is an independent risk factor and strong predictor of CMD and 
LOAD along with the other multiple target end-organs (13). 
Additionally, aortic stiffness may be considered the nexus be-
tween cardiac, renal, brain and other end-organs associated 
with obesity and T2DM (13).  Recently, Markus et al were able 
to demonstrate that elevations of glucose and insulin were posi-
tively associated with vascular stiffness (14).  These multiple 
known abnormalities associated with obesity and T2DM along 
with the gross observations of excessive adipose tissue accu-
mulation around the coronary, pericardial and thoracic aorta 
in diet-induced obesity female Western models and the db/db 
models (2, 15, 16) prompted this ultrastructural transmission 
electron microscopic (TEM) observational investigation of the 
diabetic db/db thoracic aorta and treatment with empagliflozin, 
a SGLT2 inhibitor.  
The goal of this study is to investigate the ultrastructural re-
modeling in the diabetic db/db (DBC) conduit thoracic aorta as 
compared to the CKC and to observe if empagliflozin (EMPA) 
ameliorates aberrant remodeling since the effects EMPA treat-
ment has been previously examined in the diabetic db/db brain 
(2, 15, 16).  
Materials and Methods 
Animals and Treatments  
Three cohorts of mice were used: lean non-diabetic con-
trols (CKC,  n  = 5), obese, insulin-resistant and diabetic  db/
db (DBC, n = 6), and db/db mice treated with the SGLT2 inhib-
itor, EMPA, to deliver 10 mg kg−1 day−1 and fed for five-weeks, 
initiated at 10 weeks of age (DBE, n = 6).  All mice were sacri-
ficed for study at 20 weeks of age.  All animal studies were ap-
proved by the Institutional Animal Care and Use Committees 
at the Harry S Truman Memorial Veterans’ Hospital and 
University of Missouri, Columbia, MO, USA (No.190), and 
conformed to the Guide for the Care and Use of Laboratory 
Animals published by the National Institutes of Health (NIH).
Eight-week-old female  db/db  (BKS.Cg-Dock7m+/+Leprdb/J; 
DBC) and wild-type control (C57BLKS/J; CKC) mice were pur-
chased from the Jackson Laboratory (Ann Harbor, MI, USA) 
and were housed under standard laboratory conditions where 
room temperature was 21–22 °C, and light and dark cycles were 
12 h each. Three cohorts of mice were used: lean non-diabetic 
controls (CKC, n = 6), obese, insulin-resistant and diabetic db/
db  (DBC,  n  = 6), and  db/db  mice treated with the SGLT2 in-
hibitor, EMPA, to deliver 10 mg kg−1 day−1 and fed for 10-weeks, 
initiated at 10-weeks of age (DBE, n = 6). All mice were sacri-
ficed for study at 20 weeks of age. We chose female mice because 
the cardiovascular phenotype has been previously characterized 
(15). 
Tissue Collection and Preparation for Transmission Electron 
Microscopy (TEM) 
Upon sacrifice (at 20-weeks of age) approximately 1-mm aortic 
ring slices from the upper 1/3 of the descending thoracic aor-
ta of CKC, DBC and DBE were immediately immersion-fixed 
and placed in a standard TEM fixative of 2% paraformaldehyde 
and 2% glutaraldehyde in 100 mM of sodium cacodylate buffer 
(pH = 7.35) for immersion fixation.  These specimens were then 
rinsed with 100nM sodium cacodylate buffer (pH 7.35) contain-
ing 130 mM sucrose.  Secondary fixation was performed using 
1% osmium tetroxide (Ted Pella, Inc., Redding, CA, USA) in 
cacodylate buffer using a Pelco Biowave (Ted Pella) operated at 
100 W for 1 min. Specimens were next incubated at 4 °C for 1 h, 
then rinsed with cacodylate buffer, and further rinsed with dis-
tilled water. En bloc staining was performed using 1% aqueous 
uranyl acetate and incubated at 4 °C overnight, then rinsed with 
distilled water. Using the Pelco Biowave, a graded dehydration 
series (e.g., 100 W for 40 s) was performed using ethanol, transi-
tioned into acetone, and dehydrated tissues were then infiltrated 
with Epon resin (250 W for 3 min) and polymerized at 60 °C 
overnight. Ultrathin sections were cut to a thickness of 85 nm 
using an ultramicrotome (Ultracut UCT, Leica Microsystems, 
Wetzlar, Germany) and stained using Sato’s triple lead solution 
stain and 5% aqueous uranyl acetate.  Multiple images were ac-
quired for study group at various magnifications with a JOEL 
1400-EX TEM JEOL (JEOL, Peabody, MA, USA) at 80 kV on a 
Gatan Ultrascan 1000 CCD (Gatan, Inc., Pleasanton, CA, USA).
ds.  Incidentally, these  aortas were from the same model that 
we studied the diabetic db/db DBC brain (16).  Of note, all of 
these specimens were preferably immersion fixed because we 
were also studying brains in these animals via immersion fixa-
tion in order to compare to human brain biopsies and/or rapid 
autopsy specimens to increase clinical translation of preclinical 
rodent models. 
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Results  
Light microscopy and low TEM magnification of the upper  
1/3 descending thoracic aorta 
We routinely examine toluidine blue stained slides prior to TEM 
preparations in order to localize our tissues and in this study, we 
were able to note a marked difference in remodeling between the 
control CKC and db/db diabetic DBC.  Observations indicated 
an approximately three-fold increase in volume of the adiposa 
of DBC as compared to the CKC thinner BAT adiposa (Fig. 
2).   Additionally, TEM sections were examined at low magni-
fications and assembled into a collage of images to visualize the 
ultrastructural morphology of the control descending thoracic 
aorta (Fig. 3).
Descending aorta tunica intima 
Previously, the DBC showed increased glucose levels (HbA1c), 
blood pressure, aortic and endothelial cell (EC) stiffness, and 
impaired endothelium-dependent vasorelaxation (2).  This 
study demonstrated impaired activation of endothelial nitric 
oxide synthase enzyme (eNOS) and revealed that the SGLT2 
inhibitor empagliflozin promoted glycosuria and blunted vas-
cular and renal abnormalities without raising or lowering blood 
pressure.  TEM images revealed significant shortening and con-
traction, separation, lifting and apoptosis in the DBC as com-
pared to the elongated ECs in CKC.  Also, this study was able to 
demonstrate that EMPA treatment in the DBE for last 10-weeks 
prior to sacrifice was able to significantly improve the length of 
ECs in association with a significant decrease in aortic vascular 
stiffening  (2).  
Figure 2. Brown adipose tissue differentiates to white adipose tissue in the tunica adiposa of diabetic db/db at 20-weeks. 
Panel A illustrates the control CKC aorta and note the dark staining of the BAT (dashed lines) adiposa.  Centrally there is some 
WAT unilocular adipocytes; however, they are hard to discern at the periphery of the BAT.  Note how easy it is to discern the 
special phenotype of the tunica adiposa surrounding the aorta. Panel B depicts the dramatic differentiation of BAT in panel A to 
WAT (BAT “whitening”) in the diabetic db/db (DBC) in panel B and importantly note the ~ 3-fold increase in volume of the adi-
posa. Panel C illustrates the difference in volume between the CKC and the DBC when the CKC control is overlaid and stitched 
in the DBC model.  Panel D reveals the marked expansion of the DBC’s volume in addition to its complete differentiation from 
BAT to WAT. Unfortunately, we do not have the comparable images of the models treated with empagliflozin (DBE).  Toluidine 
blue staining Panels A-D. Magnification objective x4; scale bar very small = 10µm.  AL = aortic lumen; BAT = brown adipose tissue; 
PAAT,  periadventitial adipose tissue; PVAT.  perivascular adipose tissue;  WAT, white adipose tissue.
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Descending aorta tunica intima elastolysis and elastin-derived 
products  
Elastin is a long-lived polymer with monomeric precursor tro-
poelastin and allows conduit and some resistant arteries with an 
internal elastic lamina and elastic lamella to serve as an elastin 
recoil pump associated with elastic recoil and maintenance of 
pulse pressure, pulse wave velocity in vascular hemodynam-
ics.  When elastin is damaged due to aging and accumulating 
diabetic metabolic injuries there is a loss of this recoil function 
and these vessels become stiffened with an associated increase in 
pulse wave velocity and pulse pressure which is associated with 
aortic and vascular stiffening.  
Elastolysis implies degradation by elastases, including those 
from mast cells, macrophages and lymphocytes, and are strongly 
associated with inflammaging (17).  Elastolysis was observed in 
the DBC models and associated with markedly electron dense 
protein staining that could be the result of accumulated frag-
mented proteins due to elastolysis, which could represent elas-
tin-derived peptide(s) (EDP).  These electron densities were as-
sociated with separation of the endothelial cells (endothelium) 
from the internal elastin lamina that were not noted in the CKC 
and DBE (Fig. 4, 5).
Importantly, activation of ROS via hyperglycemia (polyol - 
hexosamine flux – glucose autoxidation), advanced glycation 
products (AGE) and receptor to AGE (RAGE) - AGE/RAGE 
interactions  and subsequent matrix metalloproteinase (MMP) 
and cathepsin cysteine proteases, such as cathepsin S upregu-
lation and activation may also be responsible for the observed 
elastolysis and EDPs. 
Elastin-derived peptide(s)  created as a result of elastolysis 
and elastin degradation, which are associated with inflammation 
may accelerate aging and promote increased vascular stiffening 
in diet induced obesity Western obese mice and db/db diabetic 
models and in Western models transforming growth factor beta 
Figure 3. Transmission electron micrograph collage of descending thoracic aorta.  This collage depicts each tunica coating 
of the aorta.  As one passes from the lumen tunica intima to the multiple layers of the vascular smooth muscle cells (VSMCs) of 
the tunica media (note the elastin lamellar unit is outlined by yellow dashed lines) to the most abluminal adventitia composed 
of the compact dense collagen type I to the loose  areolar type III collagen that gradually gives way to the discernible pheno-
typic abluminal tunica adiposa.  The adiposa is sparsely decorated by white adipose tissue (WAT) and unilocular adipocytes at 
its periphery and is composed almost entirely of multilocular brown adipose tissue (BAT) adipocytes. Note that both BAT and 
WAT are illustrated with BAT adipocytes have multilocular lipid droplets and increased numbers of electron dense mitochondria 
as compared to the unilocular white adipocytes.  Each section of at least 12 individual images compose this mosaic collage and 
each has a scale bar = 10µm.  PVAT, perivascular adipose tissue or tunica adiposa.
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Figure 4. Elastolysis and elastin-derived products (EDP) in diabetic DBC. 
Panel A illustrates the normal appearance of the endothelial cell in relation to the internal elastic lamina (IEL) in control CKC 
and note the tight adherence of the endothelial cells (EC) to the IEL.  Also note the prominent adherens junction of the vascular 
endothelial cadherin (VE-Cadherin) (arrow). Panel B-D depict marked remodeling changes in the obese diabetic DBC models as 
compared to control image in Panel A. These phenotypic changes may depict activation and dysfunction of ECs. Panel B depicts 
the vacuole (V) and vesicles (v) in the EC along with an increase in weibel palade bodies (WP) with separation of the EC from the 
IEL (double arrows).  Panel C depicts EC thinning and even further separation from the IEL (double arrows) and importantly note 
the marked electron dense bodies within the intimal space that may represent IEL fragments of EDPs in this area of elastolysis, 
which are also present in panel D.  Magnification x10 000; scale bar = 0.2 µm.
Figure 5. Addition layering of elastin in DBC ameliorated with empagliflozin.  Panel A illustrates the tightly adherent en-
dothelial cell (EC) to the internal elastic lamina (IEL) and low magnification was depicted purposefully to show more  of the en-
dothelium.  Panel B depicts not only degradation of elastin lamella (EL) but also the ‘addition layering phenomenon’ of elastin 
as well as the functional lamellar unit in the DBC (outlined in yellow dashed oval). This representative image in panel B was a 
constant finding in the aortas in the DBC models.  Panel C reveals the amelioration of elastin lamella degradation as well as the 
lack of addition layering of elastin.  Varying magnifications in upper corner and scale bars depicted lower corner of each image. 
AL, aortic lumen; PGN, proteoglycan; VSMC,  vascular smooth muscle cell.  
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and neuramidase were increased (18).  Importantly, elastolysis 
and formation of EDPs (electron dense elastin fragments) were 
not observed in the CKC or the empagliflozin treated DBE. 
Descending thoracic ‘additional layering’ of elastin lamella in 
tunica media  
There were no observations of any major remodeling changes 
such as matrix proteoglycan expansion as in the lean hyperten-
sive Ren2 model in the DBC as compared to the CKC control 
in regard to vascular smooth muscle cells within the media 
(19).  However, observations demonstrated marked remodeling 
changes not only to the internal elastic lamina but also to the 
elastin lamella and the lamellar units within the tunica media of 
the DBC.  Each elastin lamella layer demonstrated degradation 
and an ‘additional layering phenomenon’ of elastin to the elastin 
lamellar units of the media (Fig. 5).  While there are definite 
observational changes of degradation/elastolysis to the internal 
elastin lamina and the lamellar units in DBC there is also known 
to be an associated increase in lysyl oxidase, which may be re-
sponsible for the crosslinking of elastin in the db/db diabetic 
with hyperglycemia and this may be related to the ‘additional 
layering phenomenon’ of the elastin lamella of the lamellar units 
observed as occurred in the response to injury mechanisms in 
DBC (20). 
Tunica adiposa remodeling in female diabetic db/db DBC  
The descending thoracic aorta adiposa in CKC and healthy hu-
mans is normally constituted by thermogenic, anti-inflamma-
tory multilocular BAT adipocytes and our specimens were spe-
cifically obtained from the upper 1/3 of the descending aorta, 
This finding in the thoracic aorta is in contrast to the abdominal 
aorta, which is known to be comprised entirely of proinflamma-
tory unilocular white adipose tissue in health and controls (21). 
However, during the development of obesity, insulin resistance, 
leptin resistance and T2DM the BAT in CKC descending aorta 
differentiates to large unilocular proinflammatory WAT adipo-
cyte phenotypes in DBC.  Further, these adipocytes undergo 
marked engorgement due to storage of excessive nutrient intake 
due to hyperphagia associated with lack of cellular signaling of 
the satiety hormone leptin.  This is thought to result in the de-
velopment of huge hypertrophic adipocytes with expansion of 
lipid droplets by gorging until the outer plasma membrane thins 
with loss of organelles (Fig. 6).  This thinning and engorgement 
of adipocytes continue until their plasma membrane rupture 
and allows for the release of toxic lipids (free fatty acids, sphin-
golipids,  diacylglycerol (DAG) and ceramides) into the intersti-
tial matrix.  The presence of these toxic lipids in the interstitial 
matrix incites acute and eventually chronic inflammation with 
macrophage accumulation.   This chronic infiltration of multiple 
inflammatory cells are largely due to the increase in monocyte 
chemoattractant protein-1 (MCP-1) as in diet-induced obesity 
Western preclinical models (22) plus other factors that may be 
responsible for the further aberrant remodeling changes within 
the adiposa of descending thoracic aortas (Fig. 6). 
There is considerable plasticity in mature adipocytes in order 
to maintain homeostasis in response to their environment (22). 
The previous aberrant remodeling images (Figs. 1, 2, 6) depict-
ing differentiation of BAT to WAT adipocyte phenotypes is vis-
ible evidence of this plasticity.  This plasticity is illustrated and 
discussed in greater depth by Grigoras et al (23).  The following 
illustration attempts to assist in the understanding of the related 
known vascular aortic stiffening that is noted in DBC, which is 
founded on this plasticity (Fig. 7).   
There is extreme thinning of the plasma membrane in the 
DBC (0.5 to 0.75nm) as compared to the 0.5 to 1µm in CKC and 
DBE.  This extreme thinning and loss of organelles including the 
mitochondria may indeed be the structural basis for the DBC 
adipocytes being prone to rupture (similar to blowing up a bal-
loon until it bursts).   
Thinning of the WAT adipocyte plasma membrane and rup-
ture appears to be associated with regions of extreme electron 
densities within the plasma membrane and associated with the 
loss of cytoplasmic organelles in DBC.  These similar findings 
have been noted by Giordano et al (24) in db/db models of obe-
sity/T2DM.  They stained WAT adipocytes in culture and in vivo 
with calcium von Kossa stain to demonstrate that hypertrophic 
WATs stained positive for calcium and to further demonstrate 
that these adipocytes depict ultrastructural features of stressed 
cells and may die of pyropoptosis (an inflammatory mode of 
cell death).  They also were able to demonstrate that these WAT 
adipocytes were associated with crown like structures (CLS) of 
macrophages similar to our studies.  Additionally, this study also 
demonstrated the presence of other inflammatory cells includ-
ing mast cells and occasional lymphocytes. 
Proinflammatory and profibrotic tunica adiposa in diabetic  
db/db DBC aorta  
There were occasional resident first responder mast cells in the 
adiposa of control CKC models, but one had to hunt extensively 
to find macrophages and even more so to observe lymphocytes; 
however, in the diet-induced obesity models such as the Western 
model fed a high sucrose/fructose and high fat diet one could 
readily find a host of inflammatory cells due to obesity, insulin 
resistance and impaired glucose tolerance.  In both the Western 
and the DBC models there is an interaction of immune cells and 
adipocytes (11) 
Adipobiology 10, 2019
Ultrastructure of db/db aorta in empagliflozin treatment  48 RESEARCH ARTICLE
In the DBC, the WAT unilocular adipocyte models revealed 
an even greater inflammatory response with macrophage crown 
like structures (CLS) in a response to injury of the plasma mem-
brane with plasma membrane thinning, loss of organelles/mito-
chondria and rupture of engorged WAT adipocytes (Figs. 8-10). 
When the thinned adipocyte ruptures it allows toxic FFA, oxi-
dized lipids, ceramides and diacylglycerol (DAG) to leak from 
the adipocytes and be expelled into the interstitial matrix, which 
incite the first responder mast cells and a monocyte chemo-
tactic protein – 1 (MCP-1) chemokine response and activate 
the ingress of inflammatory macrophages, which dependently 
or independently may also incite lymphocyte cell ingress (25-
28).  Importantly, the chronic inflammation with macrophages 
are capable of forming what are commonly termed crown-like 
structures (CLS) (Fig. 8).  Importantly, these findings were not 
present in the empagliflozin treated DBE, since they are pro-
tected from the differentiation of multilocular, thermogenic and 
anti-inflammatory BAT adipocytes to unilocular proinflamma-
tory WAT adipocytes.
Discussion   
While the focus of this observational study has been primarily 
adiposa  and adventitia, each layer has been presented and TEM 
findings were noted in each of the sections regarding CKC, DBC 
and DBE:  intima (Fig. 4), media (Figs. 3, 5), adventitia and adi-
posa in the descending aorta (Figs. 1-3, 6-10).  It is interesting 
Figure 6. Multilocular brown adipose tissue (BAT) in control CKC differentiates to unilocular white adipose tissue (WAT) 
in diabetic DBC.  Panel A illustrates the normal tunica adiposa in the control CKC and note the multilocular BAT adipocytes with 
diameter between 25-30 micrometers.  Panels B and C depict the complete differentiation from multilocular BAT adipocytes to 
unilocular WAT adipocytes and note the hypertrophy between 80-100 micrometer as compared to the CKC in panel A (yellow 
double arrows).  Panel C depicts a rupture of the unilocular WAT adipocyte in diabetic db/db DBC models (red open arrows). 
Panel D illustrates that not all hypertrophic WAT adipocytes are in the process of rupture and note the two adjacent adipocytes 
with the upper one displaying an intact plasma membrane (PM) with intact electron dense mitochondria (Mt) and the lower 
adipocyte depicting a loss of integrity with multiple interruptions or loss of the plasma membrane (PM) (open red arrows). 
Panel E demonstrates that 10 weeks of empagliflozin treatment protects the BAT adipocyte from undergoing the differentia-
tion as illustrated in the DBC models (Panels B-D).  Importantly, note the accumulation of toxic lipid extrusions (asterisks) in 
panel d.  Further, note the accumulation of collagen within the interstitium between these two adipocytes (D and d). Also, note 
the marked electron densities in the plasma membranes which might represent calcium depositions as discussed later.  DAG, 
diacylglycerol; FFA, free fatty acids; Ld = lipid droplet(s); Ox, oxidized. 
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Figure 7. A spectrum of phenotypic remodeling from CKC control to obese, db/db DBC.  This illustration utilizing transmis-
sion electron micrographs from the CKC and DBC models assist in illustrating the spectrum of adipose tissue and adipocyte 
plasticity in these models and provides a possible sequence of events (1 through 4).   Some of the major toxicities are listed in the 
lower right-hand box plus the emerging role of PRDM16 domain.  Aldo, aldosterone; Ang II,  angiotensin II; BAT, brown adipose 
tissue;  CKC = control heterozygous model; DBC = db/db diabetic models; Ins, insulin; IRS-1, Insulin receptor substrate-1; Ld, lipid 
droplets;  MΦ. macrophage; Mt. mitochondria; PRDM16, PR domain zinc finger protein 16; Red open arrows, rupture of plasma 
membranes; ROS, reactive oxygen species; T2DM,  type 2 diabetes mellitus;  WAT, white adipose tissue. 
that there was no observable increased thickness or compact-
ness in the adventitia tunica compacta similar to the previous 
Ren2 lean hypertensive model (29); however, the injury mecha-
nisms were different in that this DBC model as the C57BLKS/J 
background did not demonstrate nearly the elevated blood pres-
sure at this age of 20 weeks when compared to the much younger 
(9-10-weeks of age) Ren2 lean hypertensive models.  Addition-
ally, others have noted that db/db models do not always have 
hypertension and further, hypertension is known to be age-de-
pendent and may also depend on the background upon which 
the genetic model is created (30).  
The DBC did demonstrate obesity and T2DM and all of its as-
sociated injury mechanisms similar to the diet-induced obesity 
Western as well as insulin resistance and of course the marked 
hyperglycemic – glucotoxic phenotype injury model (16, 31). 
Previously, mean glucose ranges have been shown to be in 
the range of 100 mg/dL in the heterozygous lean non-diabetic 
(CKC) models; 500 mg/dL for the homozygous obese, insulin 
resistant and diabetic db/db (DBC) male and female models and 
in the 200 mg/dL range in the EMPA treated models of the db/
db mice (16, 31).   
Empagliflozin treatment protected the BAT from differen-
tiating to WAT and we know at least one of the mechanisms 
was by lowering the toxicities of hyperglycemia from a mean of 
500 mg/dL range of glucose to a mean of around 200 mg/dL in 
the DBE as compared to the mean of 100 mg/dL in the CKC 
(16, 31).  In doing so, EMPA also improved vascular stiffening 
of the aorta and thus protected the multiple target end-organs 
known to affect T2DM.  This is possible by protecting the adi-
posa and its BAT protective anti-inflammatory and anti-obesity 
functions.  These possible mechanisms are thought to include 
protective anticontractile functions of the adiposa as it is now 
considered to be a virtual endocrine organ with many protective 
adipokines and adipocyte-derived vasorelaxant factors that are 
lost with the differentiation to proinflammatory, procontractile 
and proatherogenic WAT.  
The tunica adiposa is an important vascular structural and 
functional construct of the wall of descending aorta, which may 
certainly continue to be the frontier of knowledge since it is able 
to secrete hundred of adipokines with endocrine and paracrine 
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Figure 8. Tunica adiposa is pro-inflammatory in DBC with crown-like structures (CLS) Panel A illustrates the findings of mul-
tilocular brown adipose tissue (BAT) without any inflammatory cells.  Panels B and C depict the accumulation of macrophages 
(MΦ ) with crown like structures (CLS) in the adiposa.  Panels D and E each display macrophages and not that in panel E the 
actual binding of the macrophage to the plasma membrane of the unilocular adipocyte.  Panel F is a higher magnification of the 
mast cell (MC) noted in the bottom right of panel C.  These images depict the multiple labeled inflammatory cells in the adiposa 
– PVAT of the DBC models with varying magnifications and scale bars labeled.  The macrophage with crown-like structures (CLS) 
was the most common inflammatory cell and included some mast cells, which were only occasionally noted in the control and 
DBE empagliflozin treated models (DBE).  Importantly, there were no CLS in the CKC and DBE.      ECM, extracellular matrix; FB, 
fibroblast;  Ld,  lipid droplets; Lg,  lipid granules; Mt,  mitochondria; 
systemic and local functions.  Adipokines such as adipocyte-
derived vasoactive relaxing factors include the gasotransmitters 
(nitric oxide and hydrogen sulfide), adiponectin, leptin, hydro-
gen peroxide, angiotensin 1-7, methyl palmitate and others yet 
to be possibly identified.  Importantly, these anticontractile ef-
fects are lost under condition of obesity (32).  Also, we have to 
include the inflammatory, fibrotic and angiogenic adipokines 
such  MCP-1, TNF-alpha, TGFβ, IL-6, IL-1β, angiopoietin-like 
protein 2 and omentin all of which may interact in not only the 
process of atherogenesis but also in better understand the pro-
cess of vascular stiffening (27, 31).
There are multiple known metabolic toxicities found in the 
female and male diabetic preclinical DBC and human T2DM 
subjects, which includes glucotoxicity, advanced glycation end 
products and its receptor (AGE/RAGE) interaction, lipotoxicity, 
insulin resistance with hyperinsulinemia, leptin resistance with 
hyperleptinemia, systemic and local adiposa renin angiotensin 
aldosterone and receptor (RAAS) activation, hypothalamic pitui-
tary adrenal (HPA) dysfunction, oxidative and nitrosative stress 
(ROS/NOS) activation, chronic inflammatory stress in adiposa 
and visceral – omental depots, hyperhomocysteinemia and hy-
peruricemia.  These toxicities are capable of acting individually 
or synergistically and since there are so many variables it is likely 
that they are constantly working synergistically especially in a ge-
netic leptin receptor deficient model that is constantly stimulated 
to consume its high caloric intake and driven by hyperleptinemia 
and leptin resistance with impaired leptin cellular signaling as a 
result of the point mutation of the leptin receptor in this db/db 
DBC model.  In addition to the these metabolic toxicities there 
may be a central mechanism in regards to tunica adiposa dysfunc-
tion that may be referred to as an ‘obesity triad’, which consists 
of adiposa hypoxia due to adipocyte expansion and hypertrophy, 
inflammation as demonstrated in the CLS and oxidative stress, 
which has been demonstrated in db/db models (2, 33).
Certain limitations apply to this study including the follow-
ing   this study was limited to immediate immersion fixation as 
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would be done with human autopsy or biopsy specimens; ii. this 
study was limited to observational findings without quantifica-
tion; iii. while this study is only a snapshot in time it does allow 
for the comparison of control CKC to the obese diabetic DBC 
and to the DBC treated with empagliflozin DBE at the same 
point in time.  Importantly, this study is the same db/db model as 
in the studies of aortic vascular stiffness of the DBC at 20-weeks 
of age (2) and a four-week younger model at 16-weeks of age 
(33), which does allow for some functional correlations as well 
as these ultrastructural observations.  
The question often arose during this study of the subcutane-
ous and visceral adipose depots:  Why are subcutaneous adipose 
depots resistant to inflammation and the visceral adipose tissue 
including aortic WAT adiposa depot prone to inflammation? 
The answers must certainly lie in their anatomic location and 
their primary importance to the tissues they serve in addition 
to possible differences of genetic - epigenetic programs available 
in these specific depots (34).  Throughout this paper author has 
used the term differentiation of BAT in control CKC  to WAT in 
the DBC and many refer to this phenomenon as BAT whitening 
(35, 36). 
Conclusion
The diabetic db/db DBC has been able to demonstrate both ex-
pected and novel findings in the adiposa and these findings will 
help to better understand the effects of obesity, insulin/leptin re-
sistance and T2DM regarding not only the adiposa but also the 
descending thoracic aorta and ultrastructural remodeling effects 
of each tunica of the aorta that accompany aortic vascular stiff-
ening – stiffness with significant kidney and brain remodeling 
(2, 37).  It is hopeful that the crossover of knowledge between 
these ultrastructural images and the discipline of functional mo-
lecular biology may lead to advances in the study of cardiometa-
bolic adipobiology (38-40).
Figure 9. Diabetic db/db DBC are inflammatory and  profibrotic.  This multi-paneled image depicts the mostly the profibrotic 
findings in the DBC in red outlines.  Importantly, empagliflozin treatment (panels C and F outlined in blue) was observed to 
protect the differentiation of the BAT (multilocular) to WAT unilocular adipocytes as in the DBC (panels B, F, G, and H). Panels E, 
G and H demonstrate the vulnerable (prone to rupture) disrupted adipocyte with loss of cellular integrity with loss of organelles 
to produce energy and provide proper signaling. Cap = capillary; Ld = lipid droplet(s); Vv = capillary vasa vasorum.
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